composição farmacêutica compreendendo inibidor de pde9
a presente invenção confere uma composição farmacêutica compreendendo um inibidor de pde9. especificamente, o inibidor de pde9 é (s)-7-(2-metoxi-3,5-dimetilpiridin-4-il)-1-(tetra-hidrofuran-3-il)-1h-pirazolo[4,3-c]quinolin-4(5h)-ona ou sais farmaceuticamente aceitáveis da mesma. The present inventio...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MAI MIYAMOTO ROBERT LAI ISHANI SAVANT-LANDRY BHASKAR REGE SADAHARU KOTANI EDGAR SCHUCK KANTA HORIE |
| description | a presente invenção confere uma composição farmacêutica compreendendo um inibidor de pde9. especificamente, o inibidor de pde9 é (s)-7-(2-metoxi-3,5-dimetilpiridin-4-il)-1-(tetra-hidrofuran-3-il)-1h-pirazolo[4,3-c]quinolin-4(5h)-ona ou sais farmaceuticamente aceitáveis da mesma.
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112019023557A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112019023557A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112019023557A23</originalsourceid><addsrcrecordid>eNrjZLBMzs8tyC_OPLz88OJ8hbTEotzE5MOrSksykxMVQFJFqal5KUCUr5CZl5mUmZJfpJCSqlCQkmrJw8CalphTnMoLpbkZVN1cQ5w9dFML8uNTiwsSk1PzUkvinYIMDY0MDC0NjIxNTc0djYyJVQcA8Kgybg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>composição farmacêutica compreendendo inibidor de pde9</title><source>esp@cenet</source><creator>MAI MIYAMOTO ; ROBERT LAI ; ISHANI SAVANT-LANDRY ; BHASKAR REGE ; SADAHARU KOTANI ; EDGAR SCHUCK ; KANTA HORIE</creator><creatorcontrib>MAI MIYAMOTO ; ROBERT LAI ; ISHANI SAVANT-LANDRY ; BHASKAR REGE ; SADAHARU KOTANI ; EDGAR SCHUCK ; KANTA HORIE</creatorcontrib><description>a presente invenção confere uma composição farmacêutica compreendendo um inibidor de pde9. especificamente, o inibidor de pde9 é (s)-7-(2-metoxi-3,5-dimetilpiridin-4-il)-1-(tetra-hidrofuran-3-il)-1h-pirazolo[4,3-c]quinolin-4(5h)-ona ou sais farmaceuticamente aceitáveis da mesma.
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.</description><language>por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200602&DB=EPODOC&CC=BR&NR=112019023557A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200602&DB=EPODOC&CC=BR&NR=112019023557A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MAI MIYAMOTO</creatorcontrib><creatorcontrib>ROBERT LAI</creatorcontrib><creatorcontrib>ISHANI SAVANT-LANDRY</creatorcontrib><creatorcontrib>BHASKAR REGE</creatorcontrib><creatorcontrib>SADAHARU KOTANI</creatorcontrib><creatorcontrib>EDGAR SCHUCK</creatorcontrib><creatorcontrib>KANTA HORIE</creatorcontrib><title>composição farmacêutica compreendendo inibidor de pde9</title><description>a presente invenção confere uma composição farmacêutica compreendendo um inibidor de pde9. especificamente, o inibidor de pde9 é (s)-7-(2-metoxi-3,5-dimetilpiridin-4-il)-1-(tetra-hidrofuran-3-il)-1h-pirazolo[4,3-c]quinolin-4(5h)-ona ou sais farmaceuticamente aceitáveis da mesma.
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBMzs8tyC_OPLz88OJ8hbTEotzE5MOrSksykxMVQFJFqal5KUCUr5CZl5mUmZJfpJCSqlCQkmrJw8CalphTnMoLpbkZVN1cQ5w9dFML8uNTiwsSk1PzUkvinYIMDY0MDC0NjIxNTc0djYyJVQcA8Kgybg</recordid><startdate>20200602</startdate><enddate>20200602</enddate><creator>MAI MIYAMOTO</creator><creator>ROBERT LAI</creator><creator>ISHANI SAVANT-LANDRY</creator><creator>BHASKAR REGE</creator><creator>SADAHARU KOTANI</creator><creator>EDGAR SCHUCK</creator><creator>KANTA HORIE</creator><scope>EVB</scope></search><sort><creationdate>20200602</creationdate><title>composição farmacêutica compreendendo inibidor de pde9</title><author>MAI MIYAMOTO ; ROBERT LAI ; ISHANI SAVANT-LANDRY ; BHASKAR REGE ; SADAHARU KOTANI ; EDGAR SCHUCK ; KANTA HORIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112019023557A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MAI MIYAMOTO</creatorcontrib><creatorcontrib>ROBERT LAI</creatorcontrib><creatorcontrib>ISHANI SAVANT-LANDRY</creatorcontrib><creatorcontrib>BHASKAR REGE</creatorcontrib><creatorcontrib>SADAHARU KOTANI</creatorcontrib><creatorcontrib>EDGAR SCHUCK</creatorcontrib><creatorcontrib>KANTA HORIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MAI MIYAMOTO</au><au>ROBERT LAI</au><au>ISHANI SAVANT-LANDRY</au><au>BHASKAR REGE</au><au>SADAHARU KOTANI</au><au>EDGAR SCHUCK</au><au>KANTA HORIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>composição farmacêutica compreendendo inibidor de pde9</title><date>2020-06-02</date><risdate>2020</risdate><abstract>a presente invenção confere uma composição farmacêutica compreendendo um inibidor de pde9. especificamente, o inibidor de pde9 é (s)-7-(2-metoxi-3,5-dimetilpiridin-4-il)-1-(tetra-hidrofuran-3-il)-1h-pirazolo[4,3-c]quinolin-4(5h)-ona ou sais farmaceuticamente aceitáveis da mesma.
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112019023557A2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | composição farmacêutica compreendendo inibidor de pde9 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A03%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MAI%20MIYAMOTO&rft.date=2020-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112019023557A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |